Work With An In-Country Clinical Trial Depot To Increase Efficiency AndMaintain Compliance

It is no secret that the road to drug approval is rife with challenges ― it is long,costly, competitive, and the odds are stacked against developers. For a sponsor to get their drug to final approval, they’ll need to identify and leverage resources that yield time and cost savings while also maintaining compliance, traceability, and quality across drug development and manufacturing processes. Since clinical trials are becoming increasingly international in scope, some drug sponsors are opting to form partnerships with global contract research organizations (CROs) that can manage their trials to help them achieve these goals.

Conducting a clinical trial in the right market can be a game-changer, and partnering with a global CRO is a strategic advantage. Take Canada for instance, a power house in the clinical trial arena. Canada contributes to 4% of clinical trials worldwide, ranks fourth in the number of clinical trial sites, and leads the G7 in clinical trial productivity. Moreover, Canada offers the second-lowest trial management costs among G7countries. If you are considering a clinical trial in Canada, collaborating with an in-country clinical depot can be highly advantageous.This localized clinical material partner consolidates shipments, warehousing, and distribution to one central location, streamlining the entire process.